Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, has launched operations backed by a first financing round led by Viking Global Investors and Casdin Capital. The funds will support the acceleration of commercial operations to provide rapid access to high-quality lentiviral vectors for pre-clinical development, clinical trials, and commercialization. The contract development and manufacturing organization (CDMO) said it will provide partners with...